HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced that the U.S. Food and Drug Administration ...
Southlake, Texas, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) ("HeartSciences" or the "Company"), a medical technology company focused on ...
SANTA CLARA, Calif., December 10, 2025--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, ...
Researchers at Mount Sinai in New York City say they've developed a new artificial intelligence model designed for electrocardiogram analysis. The innovative AI approach could vastly improve the ...
Overcoming Limitations of Immortalized Cell Lines and Animal Models to Boost Translational Cardiovascular Science ...
Patient being positioned for MR study of the head and abdomen. — Image by Ptrump16. CC BY-SA 4.0 The company TeraRecon, who develop medical imaging advanced visualization, clinical AI, and workflow ...
Please provide your email address to receive an email when new articles are posted on . A deep learning algorithm applied to preoperative ECGs improved mortality risk prediction. The algorithm ran ...
The FDA's Breakthrough Device Program is intended to speed the development and review of technologies that may provide more effective diagnosis or treatment of life-threatening conditions. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results